Latest Amyotrophic lateral sclerosis Stories
Novel ZFP Therapeutic Approach Selectively Represses Expression of Huntington's Disease-Causing Gene Variant in Patient-Derived Cells and Animal Models RICHMOND, Calif., Nov.
NEWARK, Calif., Nov.
All Currently Enrolled Patients Can Continue Receiving Aldoxorubicin Therapy or Comparator Drugs; One Inclusion/Exclusion Criteria to be Amended for New Trial Patients to Add Additional Safety Measure
Patient's Planning Ensures Her Wishes are Honored CLEVELAND, Nov. 14, 2014 /PRNewswire-USNewswire/ -- Public discussions about dying are rare.
CAMBRIDGE, Mass., Nov.
Study Concludes NSI-566 Cells Survived for up to 2.5 Years After Transplantation GERMANTOWN, Md., Nov. 10, 2014 /PRNewswire/ -- Neuralstem, Inc.
Eighteenth Annual Muscle Team Set for Jan.
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.